Cyclohexane Carboxamide

Cyclohexane Carboxamide

SCHEMBL28819581

CC(C)CC(C(=O)O)n1c(-c2ccc3cc[nH]c3c2)nc2ccccc21.NC(=O)C1CCCCC1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.44
OPRL1 P41146 1/20 0.44
NR1H4 Q96RI1 12/20 0.44
OPRD1 P41143 2/20 0.38
OPRK1 P41145 2/20 0.38
OGFRL1 Q5TC84 2/20 0.38
CTSL P07711 1/20 0.37
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
VCP P55072 1/20 0.35
PDE6D O43924 1/20 0.35
ALDH1A1 P00352 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexane Carboxamide SCHEMBL28948656 0.94 NR1H4 (0.43) OPRM1OPRL1NR1H4OPRD1OPRK1
SCHEMBL29881247 0.90 OPRM1 (0.44) OPRM1OPRL1NR1H4CTSLCTSS
Cyclohexane Carboxamide SCHEMBL28819715 0.86 NR1H4 (0.49) OPRM1NR1H4OPRD1OPRK1OGFRL1
Cyclohexane Carboxamide SCHEMBL28819590 0.86 NR1H4 (0.49) OPRM1NR1H4OPRD1OPRK1OGFRL1
Cyclohexane Carboxamide SCHEMBL28819611 0.85 NR1H4 (0.59) NR1H4
Cyclohexane Carboxamide SCHEMBL28819682 0.85 NR1H4 (0.49) OPRM1NR1H4OPRD1OPRK1OGFRL1
Cyclohexane Carboxamide SCHEMBL28948660 0.85 NR1H4 (0.48) OPRM1NR1H4OPRD1OPRK1OGFRL1
Cyclohexane Carboxamide SCHEMBL28819722 0.85 NR1H4 (0.44) OPRM1NR1H4OPRD1OPRK1OGFRL1
Cyclohexane Carboxamide SCHEMBL28819483 0.85 NR1H4 (0.48) OPRM1NR1H4OPRD1OPRK1OGFRL1
SCHEMBL3573158 0.84 NR1H4 (0.62) OPRM1OPRL1NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110404073-B Methods and pharmaceutical compositions for treating hepatitis B virus infection 国家医疗保健研究所 2022-08-16 CN disclosed